Building a Foundation: Understanding Arterial Tortuosity Syndrome (ATS)
At a Glance
Arterial tortuosity syndrome (ATS) is a rare inherited connective-tissue disorder caused by changes in both copies of SLC2A10. It can twist, narrow, kink, or widen arteries, making lifelong specialist monitoring of the aorta and other vessels important.
Arterial Tortuosity Syndrome (ATS) is an exceptionally rare genetic condition that affects the body’s connective tissue, specifically the walls of the arteries. Because it is so rare—with early estimates noting only about 106 genetically confirmed individuals reported at that time—most local doctors and even many specialists may have never encountered a case in their practice [1][2].
The Meaning of Arterial Tortuosity
In a typical cardiovascular system, arteries are relatively straight, efficient tubes that carry blood. In ATS, “tortuosity” means these vessels become elongated, twisted, and looped [3]. This twisting can occur in large and medium-sized arteries throughout the body, including the aorta (the main artery from the heart) and the pulmonary arteries (which carry blood to the lungs) [3][4].
Physical manifestations of this syndrome can include:
- Tortuosity: Excessive looping or twisting of the vessels [3].
- Stenosis: Narrowing of the arteries, which can restrict blood flow [3].
- Aneurysm: Abnormal bulging or weakening of the arterial walls [3].
- Vessel Kinking: Sharp bends in the arteries that may interfere with smooth blood flow [5].
The Biology of ATS
ATS is an autosomal-recessive disorder, meaning a person must inherit a pathogenic variant—one from each parent—to develop the condition [3]. The specific gene involved is SLC2A10, which provides instructions for making a protein called GLUT10 [6].
Normally, GLUT10 acts as a transporter within cells. When this protein is missing or doesn’t work correctly due to SLC2A10 mutations, researchers propose it triggers several biological changes:
- Oxidative Stress: Cells may experience an imbalance that leads to damage from unstable molecules called reactive oxygen species (ROS) [7][8].
- TGF-β Signaling Errors: A critical growth-regulating pathway called Transforming Growth Factor beta (TGF-β) may become disorganized, sending the wrong signals to developing tissues [7][3].
- Extracellular Matrix Dysregulation: The “scaffolding” that holds cells together—made of elastin and collagen—can become fragmented and disorganized [3][9]. While these are proposed mechanisms rather than patient-specific treatments, they help explain the stretching, twisting, and narrowing in the condition.
A Wide Range of Severity
ATS affects people very differently, and the severity can range from serious issues at birth to milder cases discovered in adulthood [10][11].
- Infants and Neonates: Some babies are diagnosed before or at birth due to respiratory distress or feeding difficulties [12][13]. In severe cases, twisted arteries can press against the airway, making breathing difficult [13].
- Children and Adolescents: Many children have diffuse arterial twisting but may not have significant blockages. However, some may develop aortic-root dilation (widening where the aorta meets the heart) or severe narrowing of the pulmonary arteries [4][14].
- Adults: While rarer, some adults are diagnosed later in life. They may experience symptoms like high blood pressure in the lungs (pulmonary hypertension) or heart-related chest pain due to kinking in the coronary arteries [11][5].
Other Physical Features
Because ATS is a connective tissue disorder, it can affect parts of the body beyond the heart and lungs [3]. Common non-vascular features include:
- Skin and Joints: Skin may be soft or hyperextensible (stretchy), and joints may be overly flexible (hypermobility) [3][15].
- Hernias: Patients frequently develop hernias, particularly diaphragmatic hernias (where abdominal organs move into the chest cavity), as well as inguinal or abdominal-wall hernias [3][16].
- Facial Features: Some individuals have distinct facial traits, such as a bulbous nose or a flat philtrum (the groove between the nose and upper lip) [17].
- Eyes: Severe nearsightedness (myopia) and thinning of the cornea may occur [18].
Monitoring and Safety
Management of ATS requires a lifelong commitment to monitoring, usually led by a multidisciplinary team at a specialized center [3].
- Imaging: Regular echocardiograms, MRIs, or CT scans are used to track the size and shape of the arteries based on an individualized schedule [3][4].
- Blood Pressure Control: Doctors may consider medications like beta-blockers to help avoid hypertension and reduce the stress on arterial walls [1]. However, treatment must be individualized to maintain appropriate blood flow; you should not start, stop, or adjust these without your clinician.
- Emergency Awareness: It is vital to seek immediate medical attention for sudden, severe pain in the chest, back, or abdomen; new weakness or speech difficulty; or sudden, severe shortness of breath [5][19][13].
Common questions in this guide
What is arterial tortuosity syndrome?
What genetic testing confirms ATS?
What symptoms and body features can ATS cause?
How is arterial tortuosity syndrome monitored?
Can medication help manage ATS?
When does ATS require emergency medical attention?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
How ATS develops
Could the SLC2A10 gene be involved in my arteries twisting?
Range of severity
Could ATS be first found in adulthood rather than at birth?
Imaging over time
Would regular echocardiograms, MRIs, or CT scans be used to track my arteries?
Get notified when new evidence is published on Arterial tortuosity syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (19)
- 1
Arterial tortuosity syndrome: Phenotypic features and cardiovascular manifestations in 4 newly identified patients.
Esmel-Vilomara R, Valenzuela I, Riaza L, et al.
European journal of medical genetics 2023; (66(9)):104823 doi:10.1016/j.ejmg.2023.104823.
PMID: 37619836 - 2
Imaging in a Rare Case of Neonatal Arterial Tortuosity Syndrome.
Inserra MC, Di Mari A, Passaniti G, et al.
Global medical genetics 2023; (10(4)):271-277 doi:10.1055/s-0043-1775980.
PMID: 37822417 - 3
Arterial tortuosity syndrome: 40 new families and literature review.
Beyens A, Albuisson J, Boel A, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2018; (20(10)):1236-1245 doi:10.1038/gim.2017.253.
PMID: 29323665 - 4
Arterial Tortuosity Syndrome: A Longitudinal Assessment of Cardiovascular Features and Interventions From the Collaborative for Longitudinal Aortic Research in the Young (CLARITY).
Salamat B, Stephens SB, Britt JJ, et al.
American journal of medical genetics. Part A 2025; (197(11)):e64159 doi:10.1002/ajmg.a.64159.
PMID: 40613586 - 5
Arterial tortuosity syndrome with coronary artery involvement in a middle-aged female: A case report.
Shrestha P, Shah A, Gc S, et al.
Radiology case reports 2026; (21(12)):6479-6485 doi:10.1016/j.radcr.2026.09.029.
PMID: 42892871 - 6
Glucose transporter type 10-lacking in arterial tortuosity syndrome-facilitates dehydroascorbic acid transport.
Németh CE, Marcolongo P, Gamberucci A, et al.
FEBS letters 2016; (590(11)):1630-40 doi:10.1002/1873-3468.12204.
PMID: 27153185 - 7
GLUT10 deficiency leads to oxidative stress and non-canonical αvβ3 integrin-mediated TGFβ signalling associated with extracellular matrix disarray in arterial tortuosity syndrome skin fibroblasts.
Zoppi N, Chiarelli N, Cinquina V, et al.
Human molecular genetics 2015; (24(23)):6769-87 doi:10.1093/hmg/ddv382.
PMID: 26376865 - 8
GLUT10 maintains the integrity of major arteries through regulation of redox homeostasis and mitochondrial function.
Syu YW, Lai HW, Jiang CL, et al.
Human molecular genetics 2018; (27(2)):307-321 doi:10.1093/hmg/ddx401.
PMID: 29149261 - 9
Ultrastructure abnormalities of collagen and elastin in Arab patients with arterial tortuosity syndrome.
Faiyaz-Ul-Haque M, Mubarak M, AbdulWahab A, et al.
Journal of cutaneous pathology 2022; (49(7)):618-622 doi:10.1111/cup.14228.
PMID: 35302653 - 10
Case series: Arterial tortuosity syndrome confirmed by homozygous SLC2A10 variants.
AlBathi A, AlHariqi BA, Rashid T, et al.
Radiology case reports 2026; (21(8)):3504-3510 doi:10.1016/j.radcr.2026.05.005.
PMID: 42253865 - 11
Arterial tortuosity syndrome presenting as severe precapillary pulmonary hypertension in adulthood.
Baltodano Dangla CR, Romero Ríos CK, Urbina Maliaños CJ, et al.
International journal of cardiology. Congenital heart disease 2026; (25()):100683 doi:10.1016/j.ijcchd.2026.100683.
PMID: 42293359 - 12
A Rare Case of Dichorionic Twins Concordant for Arterial Tortuosity Syndrome: Case Report and Review of the Literature.
Ponziani I, Checcucci C, Masini G, Pasquini L
Fetal diagnosis and therapy 2025; (52(4)):371-376 doi:10.1159/000543596.
PMID: 39827853 - 13
A Severe Form of Arterial Tortuosity Syndrome Presenting With Significant Airway Obstruction in an Infant.
Dodge-Khatami J, Simpson SA, Dodge-Khatami A
World journal for pediatric & congenital heart surgery 2020; (11(2)):238-240 doi:10.1177/2150135119829009.
PMID: 31088211 - 14
Late Outcomes After Pulmonary Arterial Reconstruction in Patients With Arterial Tortuosity Syndrome.
Al-Khaldi A, Momenah T, Alsahari A, et al.
The Annals of thoracic surgery 2022; (113(5)):1569-1574 doi:10.1016/j.athoracsur.2021.03.063.
PMID: 33811889 - 15
Arterial Tortuosity Syndrome in a Newborn: A Case Report With Literature Review.
Al-Blushi S, Bantan NAA, Al-Abdullatif S, Taher MM
Cureus 2022; (14(12)):e32899 doi:10.7759/cureus.32899.
PMID: 36578839 - 16
Arterial tortuosity syndrome: relevance in pediatric surgery. A case report.
Pérez Gaspar M, Núñez García B, Álvarez García N, et al.
Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica 2021; (34(4)):223-227.
PMID: 34606705 - 17
Understanding the Spectrum of Mild Clinical Outcomes and Novel Findings in Arterial Tortuosity Syndrome Among Qatari Patients: Implications of SLC2A10 Mutation.
Rahmath MRK, Ibrahim H, Faiyaz-Ul-Haque M, et al.
Biomedicines 2025; (13(1)) doi:10.3390/biomedicines13010159.
PMID: 39857743 - 18
Ophthalmic findings in patients with arterial tortuosity syndrome and carriers: A case series.
Hardin JS, Zarate YA, Callewaert B, et al.
Ophthalmic genetics 2018; (39(1)):29-34 doi:10.1080/13816810.2017.1335332.
PMID: 28726533 - 19
Arterial tortuosity syndrome causing recurrent transient ischemic attacks in young adult: a case report.
Cotti Piccinelli S, Premi E, Bonacina S, et al.
BMC neurology 2021; (21(1)):464 doi:10.1186/s12883-021-02458-4.
PMID: 34847858
This page about arterial tortuosity syndrome is for informational purposes only and does not constitute medical advice. Your genetics, cardiology, and vascular specialists should interpret your diagnosis and tailor monitoring, activity, and treatment recommendations.